AIM IMMUNOTECH INC. (AIM) Net margin 2016–2025
AIM IMMUNOTECH INC. (AIM) net profit margin by fiscal year — reported net income divided by reported revenue.
-15861.4%FY2025 · since FY2016: -8154.3% → -15861.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -15861.4% | -5673.1 pp |
| FY2024 | -10188.2% | +4149.4 pp |
| FY2023 | -14337.6% | -546.8 pp |
| FY2022 | -13790.8% | +377.4 pp |
| FY2021 | -14168.1% | -5333.8 pp |
| FY2020 | -8834.4% | -2117.2 pp |
| FY2019 | -6717.1% | -4039.5 pp |
| FY2018 | -2677.7% | -787.7 pp |
| FY2017 | -1889.9% | +6264.4 pp |
| FY2016 | -8154.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice